Literature DB >> 7704564

Cost-effectiveness of preventing hip fractures in the elderly population using vitamin D and calcium.

D J Torgerson1, J A Kanis.   

Abstract

Recent evidence suggests that vitamin D and calcium can reduce the incidence of hip fracture amongst elderly women. We estimated the costs of using either parenteral vitamin D alone, or oral vitamin D plus calcium, in a number of treatment strategies. These were: all women in a community setting; women with low body mass index (BMI) in the community; women in nursing homes; women with low BMI in nursing homes. The cost per averted fracture amongst women living in the community through the use of parenteral vitamin D alone was 946 pounds, and the cost per averted hip fracture was 2317 pounds. Inclusion of calcium significantly increased the cost to 14, 240 pounds for any fracture and 22, 379 pounds for hip fractures. However, targeting either treatment on women with the lowest BMI reduced the cost of averting a hip fracture, as did targeting women living in nursing homes. After removing cost savings from treatment costs, savings to the NHS occurred for all parenteral vitamin D strategies but only one of the oral vitamin D and calcium strategies. Preventing fractures with injectable vitamin D is likely to produce savings for the NHS. The addition of calcium will increase costs significantly unless the intervention is targeted on those at high risk.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7704564

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  15 in total

1.  Community institutional healthcare: emergence from refugee status.

Authors:  J Morris; C Bowman
Journal:  J R Soc Med       Date:  1999-06       Impact factor: 5.344

Review 2.  Economic notes. Discounting.

Authors:  D J Torgerson; J Raftery
Journal:  BMJ       Date:  1999-10-02

3.  Quality of life related to fear of falling and hip fracture in older women: a time trade off study.

Authors:  G Salkeld; I D Cameron; R G Cumming; S Easter; J Seymour; S E Kurrle; S Quine
Journal:  BMJ       Date:  2000-02-05

4.  Indications on the use of vitamin D and vitamin D metabolites in clinical phenotypes.

Authors:  M L Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2010-09

Review 5.  Economic evaluations of interventions for the prevention and treatment of osteoporosis: a structured review of the literature.

Authors:  Rachael L Fleurence; Cynthia P Iglesias; David J Torgerson
Journal:  Osteoporos Int       Date:  2005-06-25       Impact factor: 4.507

6.  Population screening for osteoporosis risk: a randomised control trial of medication use and fracture risk.

Authors:  R J Barr; A Stewart; D J Torgerson; D M Reid
Journal:  Osteoporos Int       Date:  2009-06-30       Impact factor: 4.507

7.  Vitamin D deficiency: time for action. Evidence supports routine supplementation for elderly people and others at risk.

Authors:  J E Compston
Journal:  BMJ       Date:  1998-11-28

8.  Treatment of osteoporosis with vitamin D.

Authors:  J A Kanis; E V McCloskey; D de Takats; J Bernard; D M Zhang
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 9.  Vitamin D and analogues in renal bone disease and implications for osteoporosis.

Authors:  J A Kanis; E V McCloskey; M N Beneton
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

10.  Place of residence and risk of fracture in older people: a population-based study of over 65-year-olds in Cardiff.

Authors:  Julieann Brennan nee Saunders; Antony Johansen; John Butler; Mike Stone; Peter Richmond; Sarah Jones; Ronan A Lyons
Journal:  Osteoporos Int       Date:  2003-04-30       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.